Huang WW - Search Results

1

Zoledronic acid as an adjuvant therapy in patients with breast cancer: a systematic review and meta-analysis.

Huang WW, Huang C, Liu J, Zheng HY, Lin L. Huang WW, et al. Among authors: huang c. PLoS One. 2012;7(7):e40783. doi: 10.1371/journal.pone.0040783. Epub 2012 Jul 26. PLoS One. 2012. PMID: 22844410 Free PMC article. Review.

2

[The roles of soluble MICA in immune escape of breast tumor].

Ye YB, Zhou ZF, Chen Q, Li JY, Chen X, Huang WW. Ye YB, et al. Among authors: huang ww. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2008 Sep;24(9):904-7. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2008. PMID: 18782524 Chinese.

3

[mRNA expression of CK19 and CEA in peripheral blood of patients with breast cancer detected by real-time quantitative PCR].

Zheng HY, Chen Q, Ye YB, Huang WW. Zheng HY, et al. Among authors: huang ww. Zhonghua Yi Xue Za Zhi. 2008 Aug 19;88(32):2267-70. Zhonghua Yi Xue Za Zhi. 2008. PMID: 19087676 Chinese.

4

The efficacy and safety of endostar combined with taxane-based regimens for HER-2-negative metastatic breast cancer patients.

Huang W, Liu J, Wu F, Chen K, Li N, Hong Y, Huang C, Zhen H, Lin L. Huang W, et al. Oncotarget. 2016 May 24;7(21):31501-7. doi: 10.18632/oncotarget.8967. Oncotarget. 2016. PMID: 27129172 Free PMC article.

5

The effect analysis of CYP2D6 gene polymorphism in the toremifene and tamoxifen treatment in patient with breast cancer.

Zeng Y, Huang K, Huang W. Zeng Y, et al. Pak J Pharm Sci. 2017 May;30(3(Special)):1095-1098. Pak J Pharm Sci. 2017. PMID: 28671087 Clinical Trial.

6

Randomized controlled clinical trial of polyethylene glycol recombinant human granulocyte colony-stimulating factor in the treatment of neutropenia after chemotherapy for breast cancer.

Huang W, Liu J, Zeng Y, Wu F, Li N, Chen K, Hong Y, Wang L, Zhen H, Lin L. Huang W, et al. Cancer Chemother Pharmacol. 2018 Oct;82(4):607-613. doi: 10.1007/s00280-018-3639-z. Epub 2018 Jul 24. Cancer Chemother Pharmacol. 2018. PMID: 30043207 Clinical Trial.

7

Protective effect of hsa-miR-570-3p targeting CD274 on triple negative breast cancer by blocking PI3K/AKT/mTOR signaling pathway.

Wang LL, Huang WW, Huang J, Huang RF, Li NN, Hong Y, Chen ML, Wu F, Liu J. Wang LL, et al. Among authors: huang rf, huang ww, huang j. Kaohsiung J Med Sci. 2020 Aug;36(8):581-591. doi: 10.1002/kjm2.12212. Epub 2020 Apr 20. Kaohsiung J Med Sci. 2020. PMID: 32311203

8

Pseudoprogression After Palbociclib with Aromatase Inhibitors Treatment in Metastatic Breast Cancer.

Huang W, Li C, Chen M, Lin D, Wu F, Chen X, Li N, Wang L, Liu J. Huang W, et al. Onco Targets Ther. 2020 Aug 5;13:7785-7792. doi: 10.2147/OTT.S253333. eCollection 2020. Onco Targets Ther. 2020. PMID: 32943874 Free PMC article.

9

Germline mutations in 40 cancer susceptibility genes among Chinese patients with high hereditary risk breast cancer.

Li JY, Jing R, Wei H, Wang M, Xiaowei Q, Liu H, Jian L, Ou JH, Jiang WH, Tian FG, Sheng Y, Li HY, Xu H, Zhang RS, Guan AH, Liu K, Jiang HC, Ren Y, He JJ, Huang W, Liao N, Cai X, Ming J, Ling R, Xu Y, Hu CY, Zhang J, Guo B, Ouyang L, Shuai P, Liu Z, Zhong L, Zeng Z, Zhang T, Xuan Z, Tan X, Liang J, Pan Q, Chen L, Zhang F, Fan LJ, Zhang Y, Yang X, BoLi J, Chen C, Jiang J. Li JY, et al. Int J Cancer. 2019 Jan 15;144(2):281-289. doi: 10.1002/ijc.31601. Epub 2018 Nov 8. Int J Cancer. 2019. PMID: 29752822

10

A Novel Framework to Predict Breast Cancer Prognosis Using Immune-Associated LncRNAs.

Huang Z, Xiao C, Zhang F, Zhou Z, Yu L, Ye C, Huang W, Li N. Huang Z, et al. Front Genet. 2021 Jan 21;11:634195. doi: 10.3389/fgene.2020.634195. eCollection 2020. Front Genet. 2021. PMID: 33584821 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results